Next Biomedical Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	4,025	6,789	4,950	3,902	3,014	22,016
Short-Term Investments	7,513	9,305	20,766	10,388	11,783	-
Trading Asset Securities	22,065	20,904	15,892	-	-	-
Cash & Short-Term Investments	33,603	36,998	41,609	14,290	14,797	22,016
Cash Growth	-18.94%	-11.08%	191.17%	-3.43%	-32.79%	226.66%
Accounts Receivable	3,075	2,236	1,845	918.64	314.3	118.67
Other Receivables	108.97	92.97	321.39	214.28	170.84	86.52
Receivables	3,184	2,329	2,167	1,133	485.15	205.19
Inventory	2,870	3,036	2,581	2,169	1,940	1,313
Prepaid Expenses	151.98	247.28	190.08	155.85	207.32	138.44
Other Current Assets	1,116	657.75	341.35	220.7	90.8	65.69
Total Current Assets	40,925	43,267	46,888	17,968	17,521	23,739
Property, Plant & Equipment	13,944	14,018	11,270	11,428	11,735	11,918
Long-Term Investments	3,881	907.78	-	-	2,637	3,737
Other Intangible Assets	282.5	310.64	344.38	217.63	222.19	288.71
Long-Term Accounts Receivable	0	-0	-0	-0	-0	-0
Other Long-Term Assets	821.91	761.06	342.75	29.48	21.35	37.51
Total Assets	59,854	59,265	58,844	29,643	32,136	39,720
Accounts Payable	71.15	47.69	13.37	58.16	45.02	4.1
Accrued Expenses	181.81	179.5	126.23	121.14	106.93	96.48
Short-Term Debt	2,160	2,160	5,600	5,600	5,600	5,600
Current Portion of Long-Term Debt	4,393	4,493	4,539	4,897	4,800	5,200
Current Portion of Leases	38.05	39.84	26.37	41.51	35.6	32.24
Other Current Liabilities	1,169	1,124	1,579	714.37	452.97	2,115
Total Current Liabilities	8,013	8,044	11,884	11,433	11,041	13,048
Long-Term Debt	774	950.66	763.5	933.54	500	20,873
Long-Term Leases	60.41	68.49	20.58	46.9	81.63	46.55
Pension & Post-Retirement Benefits	986.45	944.49	749.44	559.45	471.1	385.02
Other Long-Term Liabilities	1,084	1,151	235.35	218.84	368.8	284.7
Total Liabilities	10,919	11,158	13,653	13,191	12,462	34,636
Common Stock	4,102	4,102	4,043	3,174	3,110	3,105
Additional Paid-In Capital	111,130	111,130	107,234	61,632	60,679	60,603
Retained Earnings	-70,743	-70,597	-70,181	-72,984	-65,367	-59,673
Comprehensive Income & Other	4,447	3,472	4,095	2,277	1,324	1,049
Total Common Equity	48,936	48,107	45,191	-5,901	-253.84	5,084
Shareholders' Equity	48,936	48,107	45,191	16,452	19,674	5,084
Total Liabilities & Equity	59,854	59,265	58,844	29,643	32,136	39,720
Total Debt	7,425	7,712	10,949	11,519	11,017	31,751
Net Cash (Debt)	26,178	29,286	30,659	2,771	3,780	-9,735
Net Cash Growth	-14.61%	-4.48%	1006.61%	-26.70%	-	-
Net Cash Per Share	3218.96	3603.03	4256.48	441.28	608.67	-2011.96
Filing Date Shares Outstanding	8.11	8.2	8.09	6.28	6.21	4.84
Total Common Shares Outstanding	8.11	8.2	8.09	6.28	6.21	4.84
Working Capital	32,912	35,224	35,004	6,536	6,480	10,691
Book Value Per Share	6036.01	5863.93	5588.37	-939.89	-40.88	1050.64
Tangible Book Value	48,653	47,796	44,847	-6,119	-476.03	4,795
Tangible Book Value Per Share	6001.16	5826.06	5545.78	-974.55	-76.65	990.97
Land	5,618	5,618	5,277	5,277	5,277	5,277
Buildings	7,318	7,316	5,786	5,786	5,786	5,786
Machinery	2,548	2,566	1,598	1,430	1,397	1,504
Construction In Progress	229.91	215.37	99.29	119.06	150.11	188.87